ReviewExpert opinion on pharmacotherapy2021

Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer.

Sun Young Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.